1. Home
  2. GEL vs MDXG Comparison

GEL vs MDXG Comparison

Compare GEL & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEL
  • MDXG
  • Stock Information
  • Founded
  • GEL 1996
  • MDXG 2006
  • Country
  • GEL United States
  • MDXG United States
  • Employees
  • GEL N/A
  • MDXG N/A
  • Industry
  • GEL Oil Refining/Marketing
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEL Energy
  • MDXG Health Care
  • Exchange
  • GEL Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • GEL 1.3B
  • MDXG 1.1B
  • IPO Year
  • GEL 1996
  • MDXG N/A
  • Fundamental
  • Price
  • GEL $10.47
  • MDXG $9.14
  • Analyst Decision
  • GEL Buy
  • MDXG Strong Buy
  • Analyst Count
  • GEL 2
  • MDXG 5
  • Target Price
  • GEL $16.00
  • MDXG $12.00
  • AVG Volume (30 Days)
  • GEL 482.2K
  • MDXG 637.3K
  • Earning Date
  • GEL 02-13-2025
  • MDXG 02-26-2025
  • Dividend Yield
  • GEL 6.29%
  • MDXG N/A
  • EPS Growth
  • GEL N/A
  • MDXG N/A
  • EPS
  • GEL N/A
  • MDXG 0.52
  • Revenue
  • GEL $3,014,767,000.00
  • MDXG $342,804,000.00
  • Revenue This Year
  • GEL N/A
  • MDXG $9.56
  • Revenue Next Year
  • GEL $0.97
  • MDXG $9.19
  • P/E Ratio
  • GEL N/A
  • MDXG $17.54
  • Revenue Growth
  • GEL N/A
  • MDXG 10.93
  • 52 Week Low
  • GEL $9.86
  • MDXG $5.47
  • 52 Week High
  • GEL $15.17
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • GEL 46.87
  • MDXG 53.81
  • Support Level
  • GEL $10.25
  • MDXG $8.50
  • Resistance Level
  • GEL $10.61
  • MDXG $9.71
  • Average True Range (ATR)
  • GEL 0.33
  • MDXG 0.29
  • MACD
  • GEL 0.09
  • MDXG -0.02
  • Stochastic Oscillator
  • GEL 53.16
  • MDXG 52.89

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a United States-based limited partnership that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: